About Nebula Genomics
Nebula Genomics is a company based in San Francisco (United States) founded in 2016 by George M Church was acquired by ProPhase Labs in August 2021. It operates as a Direct-to-Consumer (D2C), and Subscription Services. Nebula Genomics has raised $4.3 million across 1 funding round from investors including Khosla Ventures, Arch Venture Partners and ProPhase Labs. The company has 2 employees as of December 31, 2024. Nebula Genomics offers products and services including 30x Whole Genome Sequencing and 100x Whole Genome Sequencing. Nebula Genomics operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Depixus and Seven Bridges Genomics, among others.
- Headquarter San Francisco, United States
- Employees 2 as on 31 Dec, 2024
- Founders George M Church
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nebula Genomics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.3 M (USD)
in 1 rounds
-
Latest Funding Round
$4.3 M (USD), Seed
Aug 29, 2018
-
Investors
Khosla Ventures
& 11 more
-
Employee Count
2
as on Dec 31, 2024
-
Acquired by
ProPhase Labs
(Aug 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nebula Genomics
Nebula Genomics offers a comprehensive portfolio of products and services, including 30x Whole Genome Sequencing and 100x Whole Genome Sequencing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Entire genome is sequenced at 30x coverage depth.
Entire genome is sequenced at 100x coverage depth.
Unlock access to complete
Unlock access to complete
Funding Insights of Nebula Genomics
Nebula Genomics has successfully raised a total of $4.3M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.3 million completed in August 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $4.3M
-
First Round
First Round
(29 Aug 2018)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2018 | Amount | Seed - Nebula Genomics | Valuation | Khosla Ventures , Fenbushi Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nebula Genomics
Nebula Genomics has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Khosla Ventures, Arch Venture Partners and ProPhase Labs. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital firm investing in the US and UK
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nebula Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nebula Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nebula Genomics Comparisons
Competitors of Nebula Genomics
Nebula Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Depixus and Seven Bridges Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nebula Genomics
Frequently Asked Questions about Nebula Genomics
When was Nebula Genomics founded?
Nebula Genomics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Nebula Genomics located?
Nebula Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Nebula Genomics a funded company?
Nebula Genomics is a funded company, having raised a total of $4.3M across 1 funding round to date. The company's 1st funding round was a Seed of $4.3M, raised on Aug 29, 2018.
How many employees does Nebula Genomics have?
As of Dec 31, 2024, the latest employee count at Nebula Genomics is 2.
What does Nebula Genomics do?
Whole genome sequencing is offered by Nebula Genomics to decode 100 of DNA for health and ancestry insights. Services are focused on personal genomics, covering sectors like healthcare and biotechnology. Advanced DNA testing solutions, including 30x and 100x coverage, are provided for comprehensive genetic analysis. Privacy protection technology is integrated to secure genomic data. Partnerships with academic and research institutions are maintained to enhance genomic research applications.
Who are the top competitors of Nebula Genomics?
Nebula Genomics's top competitors include Helix, Benchling and BioAge Labs.
What products or services does Nebula Genomics offer?
Nebula Genomics offers 30x Whole Genome Sequencing and 100x Whole Genome Sequencing.
Who are Nebula Genomics's investors?
Nebula Genomics has 12 investors. Key investors include Khosla Ventures, Arch Venture Partners, ProPhase Labs, Heartbeat Labs, and Fenbushi Capital.